Supporting Decisions in Cancer
ENOX2
NEW Marker for Early Cancer Detection & Monitoring
PUR-C

A New and More Affordable Solution for the “Vitamin C Problem”

Traditionally, integrative practices have relied on compounding pharmacies to supply ascorbic acid to meet their Vitamin C needs.  With recent price increases and intermittent supply shortages, practitioners are seeking alternatives.  Pur-C is a new product that provides the following features.

  • Large on-hand inventory, no supply shortages or rationing
  • Rapid delivery
  • Stores at room temp with 18-month dating
  • Increased bioavailability (8x Ascorbic Acid)
  • Highest quality – tested to pharmaceutical standards
  • 100% pure pharmaceutical grade USP-FCC certified
  • Full cGMP Certification
  • Crystalline powder (pH 7.1 in solution)
  • Non-GMO, non-corn source
  • Maximum potency for improved clinical efficacy
  • Packaged in clear PET reconstitution bottles
  • Quick & easy, less than 1-minute prep
  • 100% made in USA
  • Sodium ascorbate in the Cathcart tradition
  • 50g Sodium Ascorbate per bottle 

Sodium Ascorbate harnesses the intrinsic sodium/potassium pump to provide increased intracellular bioavailability compared to traditional Ascorbic Acid formulations.  Concomitant low-sodium diets are suggested; the presence of malignant ascites is a contraindication for use.

Call or email us today to receive your limited time 20% discount offer on your first order!

(727) 564-4346

info@quicklab.com

 

Pur-C is manufactured to the highest quality standards for purity and is guaranteed to meet or exceed all requirements for dietary supplements. 

 

 These statements have not been evaluated by the Food and Drug Administration.

This product is not intended to diagnose, treat, cure, or prevent any disease.

The most common question asked by every patient with a serious chronic disease:  

"Is my Treatment Working"?

Answering that question with accuracy and confidence is one of the most complex challenges clinicians face.

QuickLab Corporation provides the only source for quantitative ENOX2 ELISA testing world-wide, helping physicians answer critical-path questions quickly and cost-effectively.  The ENOX2 marker promotes trend analysis and timely decision-making insights for implementing mid-course therapeutic modifications unlike anything available before.  Furthermore, the ENOX2 test for establishing a baseline during routine examinations.